De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?

被引：15
作者：
Silver, Jennifer A. [1 ,2 ]
Turkdogan, Sena [1 ,2 ]
Roy, Catherine F. [1 ,2 ]
Subramaniam, Thavakumar [1 ,2 ]
Henry, Melissa [2 ,3 ,4 ,5 ]
Sadeghi, Nader [1 ,2 ,6 ]
机构：
[1] McGill Univ Hlth Ctr, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H4A 3JI, Canada
[2] McGill Univ, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H4A 3JI, Canada
[3] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ H4A 3JI, Canada
[4] Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[5] Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada
[6] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H4A 3JI, Canada
来源：
CURRENT ONCOLOGY | 2022年 / 29卷 / 05期
关键词：
oropharyngeal squamous cell carcinoma; human papillomavirus; de-escalation; transoral surgery; TRANSORAL ROBOTIC SURGERY; LOCALLY ADVANCED HEAD; INDUCTION CHEMOTHERAPY; RANDOMIZED-TRIAL; NECK-CANCER; FUNCTIONAL OUTCOMES; RADIATION-THERAPY; SALIVARY-GLANDS; POSITIVE HEAD; RADIOTHERAPY;
D O I：
10.3390/curroncol29050295
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The prevalence of oropharyngeal squamous cell carcinoma has been increasing in North America due to human papillomavirus-associated disease. It is molecularly distinct and differs from other head and neck cancers due to the young population and high survival rate. The treatment regimens currently in place cause significant long-term toxicities. Studies have transitioned from mortality-based outcomes to patient-reported outcomes assessing quality of life. There are many completed and ongoing trials investigating alternative therapy regimens or de-escalation strategies to minimize the negative secondary effects while maintaining overall survival and disease-free survival. The goal of this review is to discuss the most recent advancements within the field while summarizing and reviewing the available evidence.
引用
收藏
页码：3668 / 3697
页数：30
相关论文
共 79 条
  • [31] GOEPFERT H, 1979, LARYNGOSCOPE, V89, P315
  • [32] Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma
    Gupta, Tejpal
    Kannan, Sadhana
    Ghosh-Laskar, Sarbani
    Agarwal, Jai Prakash
    [J]. PLOS ONE, 2018, 13 (07):
  • [33] Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
    Haddad, Robert
    O'Neill, Anne
    Rabinowits, Guilherme
    Tishler, Roy
    Khuri, Fadlo
    Adkins, Douglas
    Clark, Joseph
    Sarlis, Nicholas
    Lorch, Jochen
    Beitler, Jonathan J.
    Limaye, Sewanti
    Riley, Sarah
    Posner, Marshall
    [J]. LANCET ONCOLOGY, 2013, 14 (03) : 257 - 264
  • [34] Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
    Hanemaaijer, Saskia H.
    Kok, Iris C.
    Fehrmann, Rudolf S. N.
    van der Vegt, Bert
    Gietema, Jourik A.
    Plaat, Boudewijn E. C.
    van Vugt, Marcel A. T. M.
    Vergeer, Marije R.
    Leemans, C. Rene
    Langendijk, Johannes A.
    Voortman, Jens
    Buter, Jan
    Oosting, Sjoukje F.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [35] Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234
    Harari, Paul M.
    Harris, Jonathan
    Kies, Merrill S.
    Myers, Jeffrey N.
    Jordan, Richard C.
    Gillison, Maura L.
    Foote, Robert L.
    Machtay, Mitchell
    Rotman, Marvin
    Khuntia, Deepak
    Straube, William
    Zhang, Qiang
    Ang, Kian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) : 2486 - U290
  • [36] Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation
    Haring, Catherine T.
    Brummel, Collin
    Bhambhani, Chandan
    Jewell, Brittany
    Neal, Molly Heft
    Bhangale, Apurva
    Casper, Keith
    Malloy, Kelly
    McLean, Scott
    Shuman, Andrew
    Stucken, Chaz
    Rosko, Andrew
    Prince, Mark
    Bradford, Carol
    Eisbruch, Avraham
    Mierzwa, Michelle
    Tewari, Muneesh
    Worden, Francis P.
    Swiecicki, Paul L.
    Spector, Matthew E.
    Brenner, J. Chad
    [J]. ORAL ONCOLOGY, 2021, 121
  • [37] TRANSORAL LASER MICROSURGERY AS PRIMARY TREATMENT FOR ADVANCED-STAGE OROPHARYNGEAL CANCER: A UNITED STATES MULTICENTER STUDY
    Haughey, Bruce H.
    Hinni, Michael L.
    Salassa, John R.
    Hayden, Richard E.
    Grant, David G.
    Rich, Jason T.
    Milov, Simon
    Lewis, James S., Jr.
    Krishna, Murli
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (12): : 1683 - 1694
  • [38] Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer
    Huang, Shao Hui
    Perez-Ordonez, Bayardo
    Weinreb, Ilan
    Hope, Andrew
    Massey, Christine
    Waldron, John N.
    Kim, John
    Bayley, Andrew J.
    Cummings, Bernard
    Cho, B. C. John
    Ringash, Jolie
    Dawson, Laura A.
    Siu, Lillian L.
    Chen, Eric
    Irish, Jonathan
    Gullane, Patrick
    Hui, Angela
    Liu, Fei-Fei
    Shen, Xiaowei
    Xu, Wei
    O'Sullivan, Brian
    [J]. ORAL ONCOLOGY, 2013, 49 (01) : 79 - 85
  • [39] Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer
    Hung, Tony K. W.
    Ho, Alan L.
    Pfister, David G.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (06) : 952 - 961
  • [40] International Agency for Research on Cancer, Factsheets
12345678